Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow (FCF).
AGN Free Cash Flow Analysis
Free cash flow, a measure commonly used by analysts to assess a company's profitability, represents the cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
The Free Cash Flow is calculated using a number of methods including using Operating Cash Flow. Following is the formula to calculate Free Cash Flow based on Operating Cash Flow.
Free Cash Flow = Operating Cash Flow - Capital Expenditures
Using above formula to calculate Free Cash Flow for Argenica Therapeutics Limited (AGN), the free cash flow value is -1.05M.
All amounts in AUD
Argenica Therapeutics Limited has a negative free cash flow as per the latest annual Cash flow statement released by the company. Positive free cash flow is cruscial for the financial health of a company, which can be used to pay dividends, expand operations, and deleverage its balance sheet (i.e., reduce debt).
AGN Cash Flow Statement History
Following table shows the history of Cash Flow Statements sheet for Argenica Therapeutics Limited (ASX:AGN).
|30 Jun 2021||30 Jun 2020|
|Change To Netincome||268.22k||268.22k|
|Change To Account Receivables||-92.6k||-59.45k|
|Change To Liabilities||-199.72k||615.88k|
|Change To Operating Activities||7.19k||7.19k|
|Total Cash From Operating Activities||-1.05M||-100.83k|
|Other Cashflows From Financing Activities||120||120|
|Total Cash From Financing Activities||7.85M||687.09k|
|Change In Cash||6.8M||586.26k|
|Issuance Of Stock||7.85M||687.09k|